Molica, Serena
 Distribuzione geografica
Continente #
NA - Nord America 100
AS - Asia 86
EU - Europa 63
SA - Sud America 19
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 271
Nazione #
US - Stati Uniti d'America 96
SG - Singapore 44
SE - Svezia 19
IT - Italia 18
BR - Brasile 16
CN - Cina 15
IN - India 10
DE - Germania 8
FR - Francia 5
IE - Irlanda 5
FI - Finlandia 3
HK - Hong Kong 3
ID - Indonesia 3
MX - Messico 3
VN - Vietnam 3
AR - Argentina 2
BD - Bangladesh 2
GB - Regno Unito 2
JO - Giordania 2
AT - Austria 1
CA - Canada 1
EU - Europa 1
JP - Giappone 1
KR - Corea 1
MA - Marocco 1
MY - Malesia 1
PK - Pakistan 1
PL - Polonia 1
PY - Paraguay 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 271
Città #
Singapore 24
New York 18
Ashburn 12
Chandler 11
Florence 6
Hyderabad 6
Dublin 5
Dallas 4
Beijing 3
Hong Kong 3
Jakarta 3
Los Angeles 3
Rome 3
San Mateo 3
Amman 2
Atlanta 2
Boston 2
Düsseldorf 2
Frankfurt am Main 2
Hefei 2
Helsinki 2
Princeton 2
Pune 2
Quận Bình Thạnh 2
Agadir 1
Almirante Brown 1
Brasília 1
Bremen 1
Buenos Aires 1
Buffalo 1
Chicago 1
Cleveland 1
Curitiba 1
Denver 1
Detroit 1
Dhaka 1
Feira de Santana 1
Guarulhos 1
Ho Chi Minh City 1
Itatiba 1
Jackson 1
Jaguariaíva 1
Johannesburg 1
Karachi 1
Kent 1
Lappeenranta 1
Manaus 1
Marseille 1
Marília 1
Miguel Hidalgo 1
Milan 1
Montes Claros 1
Moscow 1
Mumbai 1
Muniz Freire 1
Naples 1
New Delhi 1
North Bergen 1
Norwalk 1
Nova Iguaçu 1
Orem 1
Orlando 1
Passo Fundo 1
Petersburg 1
Phoenix 1
Poplar 1
Recife 1
Rock Hill 1
Salvador 1
San Jose 1
Santa Fe 1
Santa Rita 1
Seoul 1
Springfield 1
Stockholm 1
Subang Jaya 1
Taquarussu 1
Tokyo 1
Toronto 1
Valinhos 1
Venustiano Carranza 1
Vergiate 1
Warner Robins 1
Wilmington 1
Yonkers 1
Totale 185
Nome #
Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib 103
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study 94
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study 77
Totale 274
Categoria #
all - tutte 1.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 0 3 4 1 0 0 4 1 0 6 1
2022/202333 6 7 2 4 0 5 1 2 1 0 5 0
2023/202448 1 8 2 6 1 17 2 2 0 1 0 8
2024/202566 1 3 5 0 6 4 0 3 9 13 12 10
2025/2026107 26 5 15 25 29 7 0 0 0 0 0 0
Totale 274